Yoo and Company provides professional services for clients needing strategic corporate and business development expertise, market understanding and domain-specific marketing capabilities, intellectual property and asset development services, new company formation and financing, innovation engineering, and turnkey project leadership in Healthcare and Life Sciences. We have developed proven expertise and success for our clients.
STRATEGIC PLANNING & CORPORATE DEVELOPMENT
Technology Asset Valuation
Turnkey Management Insourcing
Corporate Financing Management
Executive Business Development
BUSINESS DEVELOPMENT & PARTNERSHIPS
Technology Target Validation
Executive Relationship Management
MARKETING & COMMERCIALIZATION STRATEGIES
Asset commercialization modeling
Market Creation and Penetration Planning
Customer Segmentation and Go-to-Market Analysis
New Venture Creation and Financing
Strategic Marketing and Channels Development
TECHNOLOGY DEVELOPMENT & ASSET MANAGEMENT
Intellectual Property Analysis and Portfolio Development
Market-relevant Asset Identification
Directed Market Research
DELIVERING DEEP EXPERTISE
Experienced and Thoughtful
Translational medicine planning – from early discovery research management to phase I clinical trials technology assessment and deployment.
Tech transfer partnership development – from intellectual property assessment, packaging, and proposal management to collaboration development, consortium development, and asset valuation.
New market development – from assessment of market access/unmet medical need, to health technology assessment, to bench-to-bedside translation.
New technology market validation and development – from biomarker identification, to biomarker development and predictivity scoring, to biomarker asset allocation between multiple partners.
New company formation and operational management – from opportunity exploration, to business case and business planning, to startup operations execution.
Corporate financing and exit strategy development – from angel and venture financing to private placement to liquidity and change of control management.